2020 Webinars
Accelerating Life Science Discovery by Enabling Lab and Data Automation
Immunology Drug Research: Using in vitro assays to select and support in vivo efficacy studies
Advancing our understanding of neuroinflammation: Driving a systems biology approach to re-classify brain disease
Cas-CLOVER™ “the clean alternative to CRISPR-Cas9” and piggyBac® for cell line development & engineering
Cell therapy specificity screening: Assessing off-target liabilities and generating tox data for INDs
Preclinical evaluation of antimetastatic drug candidates using a next-generation chicken embryo model
Methods to Mitigate Target Interference in Anti-Drug Antibody Assays
Effective Discovery and Validation of Cancer Drug Targets Through Scalable Genome Engineering
Protein or Not? Advanced Aggregate and Particle Analysis with the Aura
Leveraging Automated High-throughput Clonal Selection: How MicroScale Purifications Prevent Bottlenecks and Increase Success
Explore AAV formulation and stability with Big Tuna and Uncle
Protein Adsorption and Aggregation in Fill-Finish Pumping Systems: Effect of Surface Charges
Digital Bioprocessing: Addressing complexity and accelerating process development through data and automation tools
Best Practices for Small to Mid-Size Companies to Advance Drug Discovery Programs
Top 5 Data Governance Strategies for Life Sciences
IBD: pre-clinical models and translating efficacy to human disease
Optimizing personalized drug dosing for patients with drug-specific Pharmacokinetic data models
Get ahead in the race with high-quality peptide discovery and binding kinetics for therapeutic and diagnostics development
Viable Cell Density and Viability in High Throughput cell culture applications
IP and R&D Trends in Biological Sequencing
The Digital Lab. “What it is and How we get there”
Accelerating Genomic Research with Hybrid Cloud Solutions
Introduction to Protein Footprinting
Next Generation Diagnostic Assay Development Fueled by Synthetic Antibody Libraries
Automated Multi-Attribute Method (MAM) Sample Preparation
Optical Sensors for Real-time pH and Dissolved Oxygen Measurements in Cell Culture: Cell Secrets Revealed
De-risking Antibody Discovery: Tips for Success from Industry Experience
Get More DNA, and now RNA, from FFPE Tissue with Half the Effort
Predicting stability of antibody therapeutics by unfolded-state studies with high-throughput dynamic light scattering
Integration of soft-sensor technologies with CHO-cell predictive models for improved bioreactor automation & process control
What is the GDPR and how to operationalize it?
Accelerating small molecule discovery chemistry by optimizing your Design-Make-Test-Analyze workflow
Remdesivir for COVID-19: Case Study and Clinical Trial Design
Improve Translation of Humanized Animal Models for Immunotherapy
On-target development - Specificity screening of biotherapeutics to avoid off-target liabilities
Analytical Validation of CTC Enumeration using the RareCyte Platform and Implementation in a Global Clinical Trial
Overcoming Irreproducibility in Life Science Research through Recombinant Antibodies, Protein Sequencing and More
Worldwide Distributed Computing Initiative Tackling COVID-19 Drug Discovery
Testing Needs for COVID-19 and Beyond
COVID-19 Serological Test Development
DRIVE™ : Brothers in Arms to support small molecule drug discovery from Hit to IND
Embracing Telehealth and Virtual Care Delivery Post COVID-19
Engineering Optimized Anti-SARS-CoV-2 Antibody Therapeutics
Getting Back to Work – Strategies to Prepare for the Reopening of Halted Clinical Trials
Neuroinflammation in Chronic Pain – A Case for Interdisciplinary Research
Clinical Trial Data Collection for Success During and After COVID-19: From Virtual Trials, EDC to DDC, BYOD, and Beyond
The Future of Supply Chain Management Post-COVID
Antibody Testing: COVID-19 Seroprevalence Studies
High Throughput Chemical Stability Screening for Proteins
Accelerating the Clinical Development Lifecycle through Digitization
Will COVID-19 Produce a New Normal in R&D -- Faster, More Decentralized, More Digitized?
How to optimize In vivo preclinical efficacy evaluation of synergistic immuno-oncology drug candidates
Process Model Evolution with Biopharm Services
Cytokine Biomarkers of Inflammatory Response in COVID-19 Patients
Workflows for biotherapeutic higher order structure characterization
Selecting best models mediated by T, B cells and innate immune system for your pre-clinical research
Laboratory Diagnosis of SARS-CoV-2: Review of Testing Methodologies
In vitro T cell exhaustion – Development and optimization of a primary immune cell assay
Fully Human Antibody Therapeutics on RenMab Discovery Platform - A Snapshot of Project Integrum
Multiplex Serological Assays for COVID-19
Gathering evidence through biochemical and biophysical characterization of biologics
Digital Infrastructure in the COVID-19 Age: Data Security, Rapid Scalability and AI for Clinical Assays and Diagnostics
Vaccine Development for COVID-19
Developing COVID-19 Diagnostics for FDA Authorization
Predicting Viral Clearance: DOE, HTS and AAV Case Studies Using a Non-Infectious MVM Surrogate in Downstream Development
Trends from the Trenches Digital
Data Ecosystems that Accelerate Scientific Research
Fast CMC Development from DNA to IND
High throughput antibody screening using next generation synthetic antibody libraries coupled with kinetic & binning assays
Overcoming limitations of ELISAs in process-related impurity testing
Catch your capsid leaks – Uncle’s tools for AAV stability and characterization
A Pharmacogenetic (PGx) Blindspot: The prevalence and Impact of CYP2D6 Hybrid Alleles
Characterization of nanotherapeutics by dynamic light scattering
Employing a Process Optimization Strategy for Improving Biopharmaceutical Assay Workflows
Cell avidity - the best predictor for clinical efficacy of T cell therapy?
Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape
Biosensor Development Using CRISPR to Quantify Endogenous Protein Modulated by Targeted Protein Degraders
Thermal unfolding and aggregation analysis of lead antibodies and variants derived from synthetic antibody libraries
Discover Antibody Candidates Against a Panel of Hard-to-Drug GPCR Targets: A Synthetic Antibody Library Case Study
An Automated Solution for Single-Cell Gene Expression Workflows
Integrated Drug Discovery at Jubilant Biosys: Helping Biotechs achieve differentiated outcome with our 4D approach